Al-Aqar Healthcare REIT
KLSE:ALAQAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Al-Aqar Healthcare REIT
KLSE:ALAQAR
|
MY |
|
Swiss Re AG
SIX:SREN
|
CH |
|
Voltamp Transformers Ltd
NSE:VOLTAMP
|
IN |
|
F
|
Firm Capital Property Trust
TSX:FCD.UN
|
CA |
|
Cellnet Group Ltd
ASX:CLT
|
AU |
Wall Street
Price Targets
ALAQAR Price Targets Summary
Al-Aqar Healthcare REIT
According to Wall Street analysts, the average 1-year price target for ALAQAR is 1.37 MYR with a low forecast of 1.31 MYR and a high forecast of 1.47 MYR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALAQAR's stock price target?
Price Target
1.37
MYR
According to Wall Street analysts, the average 1-year price target for ALAQAR is 1.37 MYR with a low forecast of 1.31 MYR and a high forecast of 1.47 MYR.
What is Al-Aqar Healthcare REIT's Revenue forecast?
Projected CAGR
6%
For the last 14 years the compound annual growth rate for Al-Aqar Healthcare REIT's revenue is 0%. The projected CAGR for the next 2 years is 6%.
What is Al-Aqar Healthcare REIT's Operating Income forecast?
Projected CAGR
6%
For the last 14 years the compound annual growth rate for Al-Aqar Healthcare REIT's operating income is -1%. The projected CAGR for the next 2 years is 6%.
What is Al-Aqar Healthcare REIT's Net Income forecast?
Projected CAGR
13%
For the last 14 years the compound annual growth rate for Al-Aqar Healthcare REIT's net income is -3%. The projected CAGR for the next 2 years is 13%.
